{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:41:19Z","timestamp":1790023279688,"version":"4.0.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.semarthrit.2019.11.008","type":"journal-article","created":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T20:00:49Z","timestamp":1573848049000},"page":"498-502","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Concurrent anti-PM-Scl antibody-associated systemic sclerosis and inclusion body myositis \u2013 report of two cases and review of the literature"],"prefix":"10.1016","volume":"50","author":[{"given":"Soumya","family":"Chatterjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Prayson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.semarthrit.2019.11.008_bib0001","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/acn3.419","article-title":"Immune and myodegenerative pathomechanisms in inclusion body myositis","volume":"4","author":"Keller","year":"2017","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"10.1016\/j.semarthrit.2019.11.008_bib0002","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/(SICI)1097-4598(199801)21:1<115::AID-MUS15>3.0.CO;2-2","article-title":"Immune-mediated conditions and antibodies associated with sporadic inclusion body myositis","volume":"21","author":"Koffman","year":"1998","journal-title":"Muscle Nerve"},{"issue":"12","key":"10.1016\/j.semarthrit.2019.11.008_bib0003","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1212\/01.WNL.0000148588.15052.4C","article-title":"Associations with autoimmune disorders and HLA class I and II antigens in inclusion body myositis","volume":"63","author":"Badrising","year":"2004","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.semarthrit.2019.11.008_bib0004","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/01.ede.0000193605.93416.df","article-title":"Autoimmune diseases co-occurring within individuals and within families: a systematic review","volume":"17","author":"Somers","year":"2006","journal-title":"Epidemiology"},{"issue":"5","key":"10.1016\/j.semarthrit.2019.11.008_bib0005","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/jnnp.70.5.706","article-title":"Anti-Jo-1 positive inclusion body myositis with a marked and sustained clinical improvement after oral prednisone","volume":"70","author":"Hengstman","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.semarthrit.2019.11.008_bib0006","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1080\/03009742.2017.1350747","article-title":"A rare association of anti-alanine-transfer RNA synthetase (anti-PL12) syndrome and sporadic inclusion body myositis","volume":"47","author":"Giannini","year":"2018","journal-title":"Scand J Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2019.11.008_bib0007","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/MD.0b013e31824d9cec","article-title":"Inflammatory myopathies with anti-Ku antibodies: a prognosis dependent on associated lung disease","volume":"91","author":"Rigolet","year":"2012","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.semarthrit.2019.11.008_bib0008","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2169\/internalmedicine.9363-17","article-title":"Dropped head syndrome and the presence of rimmed vacuoles in a muscle biopsy in scleroderma-polymyositis overlap syndrome associated with anti-Ku antibody","volume":"57","author":"Takeshi","year":"2018","journal-title":"Intern Med"},{"issue":"1","key":"10.1016\/j.semarthrit.2019.11.008_bib0009","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3109\/s101650300014","article-title":"A case of inclusion body myositis with systemic sclerosis","volume":"13","author":"Kusaoi","year":"2003","journal-title":"Mod Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2019.11.008_bib0010","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3899\/jrheum.141206","article-title":"Inclusion body myositis in a patient with RNA polymerase III antibody-positive systemic sclerosis","volume":"42","author":"Vemulapalli","year":"2015","journal-title":"J Rheumatol"},{"issue":"15","key":"10.1016\/j.semarthrit.2019.11.008_bib0011","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1212\/WNL.0000000000003821","article-title":"Overlapping features of polymyositis and inclusion body myositis in HIV-infected patients","volume":"88","author":"Lloyd","year":"2017","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.semarthrit.2019.11.008_bib0012","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/ar147","article-title":"The human exosome: an autoantigenic complex of exoribonucleases in myositis and scleroderma","volume":"3","author":"Brouwer","year":"2001","journal-title":"Arthritis Res"},{"issue":"10","key":"10.1016\/j.semarthrit.2019.11.008_bib0013","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/art.1780351014","article-title":"Serum autoantibody to the nucleolar antigen PM-Scl. clinical and immunogenetic associations","volume":"35","author":"Oddis","year":"1992","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.semarthrit.2019.11.008_bib0014","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/art.38428","article-title":"Clinical and serologic correlates of anti-PM\/Scl antibodies in systemic sclerosis: a multicenter study of 763 patients","volume":"66","author":"D'Aoust","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"10.1016\/j.semarthrit.2019.11.008_bib0015","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/rheumatology\/keg253","article-title":"Anti-PM-Scl antibodies in a patient with inclusion body myositis","volume":"42","author":"Selva-O'Callaghan","year":"2003","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1016\/j.semarthrit.2019.11.008_bib0016","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00393-005-0664-1","article-title":"[PM-Scl antibody positive systemic sclerosis associated with inclusion-body myositis]","volume":"64","author":"Kim","year":"2005","journal-title":"Z Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2019.11.008_bib0017","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1212\/WNL.48.3.712","article-title":"Treatment of inclusion-body myositis with IVIg: a double-blind, placebo-controlled study","volume":"48","author":"Dalakas","year":"1997","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.semarthrit.2019.11.008_bib0018","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1750-3639.2009.00290.x","article-title":"Inclusion body myositis: a degenerative muscle disease associated with intra-muscle fiber multi-protein aggregates, proteasome inhibition, endoplasmic reticulum stress and decreased lysosomal degradation","volume":"19","author":"Askanas","year":"2009","journal-title":"Brain Pathol"},{"issue":"1","key":"10.1016\/j.semarthrit.2019.11.008_bib0019","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s001099900072","article-title":"Identification of an alpha-helical epitope region on the PM\/Scl-100 autoantigen with structural homology to a region on the heterochromatin p25beta autoantigen using immobilized overlapping synthetic peptides","volume":"78","author":"Bluthner","year":"2000","journal-title":"J Mol Med (Berl)"},{"issue":"5","key":"10.1016\/j.semarthrit.2019.11.008_bib0020","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.4049\/jimmunol.157.5.1823","article-title":"Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules?","volume":"157","author":"Yewdell","year":"1996","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.semarthrit.2019.11.008_bib0021","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1136\/annrheumdis-2016-210282","article-title":"Cytosolic 5\u2032-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis","volume":"76","author":"Lilleker","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.semarthrit.2019.11.008_bib0022","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/ana.410380504","article-title":"Inclusion body myositis and myopathies","volume":"38","author":"Griggs","year":"1995","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.semarthrit.2019.11.008_bib0023","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ana.24847","article-title":"Proteomics of rimmed vacuoles define new risk allele in inclusion body myositis","volume":"81","author":"Guttsches","year":"2017","journal-title":"Ann Neurol"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017219306894?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017219306894?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:03:12Z","timestamp":1758733392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017219306894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0049017219306894"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2019.11.008","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Concurrent anti-PM-Scl antibody-associated systemic sclerosis and inclusion body myositis \u2013 report of two cases and review of the literature","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2019.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}